Format

Send to

Choose Destination
Nat Rev Clin Oncol. 2018 Dec 20. doi: 10.1038/s41571-018-0155-3. [Epub ahead of print]

Myeloid immune-checkpoint inhibition enters the clinical stage.

Author information

1
Sanquin Research, Landsteiner Laboratory, and the Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Amsterdam, Netherlands. t.k.vandenberg@sanquin.nl.
2
Division of Stem Cell Transplantation and Immunotherapy, Department of Internal Medicine II, Christian-Albrechts-University, Kiel, Germany.
PMID:
30573788
DOI:
10.1038/s41571-018-0155-3

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center